FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2284398211> ?p ?o ?g. }

• W2284398211 endingPage "8794" @default.
• W2284398211 startingPage "8784" @default.
• W2284398211 abstract "AMPA receptors are glutamate-gated cation channels assembled from GluA1–4 subunits and have properties that are strongly dependent on the subunit composition. The subunits have different propensities to form homomeric or various heteromeric receptors expressed on cell surface, but the underlying mechanisms are still poorly understood. Here, we examined the biochemical basis for the poor ability of GluA3 subunits to form homomeric receptors, linked previously to two amino acid residues, Tyr-454 and Arg-461, in its ligand binding domain (LBD). Surface expression of GluA3 was improved by co-assembly with GluA2 but not with stargazin, a trafficking chaperone and modulator of AMPA receptors. The secretion efficiency of GluA2 and GluA3 LBDs paralleled the transport difference between the respective full-length receptors and was similarly dependent on Tyr-454/Arg-461 but not on LBD stability. In comparison to GluA2, GluA3 homomeric receptors showed a strong and Tyr-454/Arg-461-dependent tendency to aggregate both in the macroscopic scale measured as lower solubility in nonionic detergent and in the microscopic scale evident as the preponderance of hydrodynamically large structures in density gradient centrifugation and native gel electrophoresis. We conclude that the impaired surface expression of homomeric GluA3 receptors is caused by nonproductive assembly and aggregation to which LBD residues Tyr-454 and Arg-461 strongly contribute. This aggregation inhibits the entry of newly synthesized GluA3 receptors to the secretory pathway. AMPA receptors are glutamate-gated cation channels assembled from GluA1–4 subunits and have properties that are strongly dependent on the subunit composition. The subunits have different propensities to form homomeric or various heteromeric receptors expressed on cell surface, but the underlying mechanisms are still poorly understood. Here, we examined the biochemical basis for the poor ability of GluA3 subunits to form homomeric receptors, linked previously to two amino acid residues, Tyr-454 and Arg-461, in its ligand binding domain (LBD). Surface expression of GluA3 was improved by co-assembly with GluA2 but not with stargazin, a trafficking chaperone and modulator of AMPA receptors. The secretion efficiency of GluA2 and GluA3 LBDs paralleled the transport difference between the respective full-length receptors and was similarly dependent on Tyr-454/Arg-461 but not on LBD stability. In comparison to GluA2, GluA3 homomeric receptors showed a strong and Tyr-454/Arg-461-dependent tendency to aggregate both in the macroscopic scale measured as lower solubility in nonionic detergent and in the microscopic scale evident as the preponderance of hydrodynamically large structures in density gradient centrifugation and native gel electrophoresis. We conclude that the impaired surface expression of homomeric GluA3 receptors is caused by nonproductive assembly and aggregation to which LBD residues Tyr-454 and Arg-461 strongly contribute. This aggregation inhibits the entry of newly synthesized GluA3 receptors to the secretory pathway." @default.
• W2284398211 created "2016-06-24" @default.
• W2284398211 creator A5036290531 @default.
• W2284398211 creator A5040717921 @default.
• W2284398211 creator A5055230969 @default.
• W2284398211 creator A5073316802 @default.
• W2284398211 creator A5073378513 @default.
• W2284398211 creator A5075924434 @default.
• W2284398211 date "2016-04-01" @default.
• W2284398211 modified "2023-10-18" @default.
• W2284398211 title "Aggregation Limits Surface Expression of Homomeric GluA3 Receptors" @default.
• W2284398211 cites W1600708614 @default.
• W2284398211 cites W1744070583 @default.
• W2284398211 cites W1922786159 @default.
• W2284398211 cites W1964840357 @default.
• W2284398211 cites W1965191426 @default.
• W2284398211 cites W1973573917 @default.
• W2284398211 cites W1975483893 @default.
• W2284398211 cites W1992506418 @default.
• W2284398211 cites W1993536619 @default.
• W2284398211 cites W1997517510 @default.
• W2284398211 cites W2000300989 @default.
• W2284398211 cites W2001818485 @default.
• W2284398211 cites W2008283517 @default.
• W2284398211 cites W2015013519 @default.
• W2284398211 cites W2018945594 @default.
• W2284398211 cites W2022622840 @default.
• W2284398211 cites W2027137726 @default.
• W2284398211 cites W2031163435 @default.
• W2284398211 cites W2033082381 @default.
• W2284398211 cites W2035361538 @default.
• W2284398211 cites W2037852973 @default.
• W2284398211 cites W2044208012 @default.
• W2284398211 cites W2047310126 @default.
• W2284398211 cites W2050320981 @default.
• W2284398211 cites W2074385487 @default.
• W2284398211 cites W2074732180 @default.
• W2284398211 cites W2075663998 @default.
• W2284398211 cites W2078300126 @default.
• W2284398211 cites W2081396889 @default.
• W2284398211 cites W2090929012 @default.
• W2284398211 cites W2092990950 @default.
• W2284398211 cites W2100087262 @default.
• W2284398211 cites W2113670233 @default.
• W2284398211 cites W2123875309 @default.
• W2284398211 cites W2135999567 @default.
• W2284398211 cites W2147542138 @default.
• W2284398211 cites W2148460663 @default.
• W2284398211 cites W2167255353 @default.
• W2284398211 cites W2169578249 @default.
• W2284398211 doi "https://doi.org/10.1074/jbc.m115.689125" @default.
• W2284398211 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4861446" @default.
• W2284398211 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26912664" @default.
• W2284398211 hasPublicationYear "2016" @default.
• W2284398211 type Work @default.
• W2284398211 sameAs 2284398211 @default.
• W2284398211 citedByCount "7" @default.
• W2284398211 countsByYear W22843982112017 @default.
• W2284398211 countsByYear W22843982112018 @default.
• W2284398211 countsByYear W22843982112020 @default.
• W2284398211 countsByYear W22843982112021 @default.
• W2284398211 crossrefType "journal-article" @default.
• W2284398211 hasAuthorship W2284398211A5036290531 @default.
• W2284398211 hasAuthorship W2284398211A5040717921 @default.
• W2284398211 hasAuthorship W2284398211A5055230969 @default.
• W2284398211 hasAuthorship W2284398211A5073316802 @default.
• W2284398211 hasAuthorship W2284398211A5073378513 @default.
• W2284398211 hasAuthorship W2284398211A5075924434 @default.
• W2284398211 hasBestOaLocation W22843982111 @default.
• W2284398211 hasConcept C104292427 @default.
• W2284398211 hasConcept C104317684 @default.
• W2284398211 hasConcept C12554922 @default.
• W2284398211 hasConcept C160268369 @default.
• W2284398211 hasConcept C170493617 @default.
• W2284398211 hasConcept C185592680 @default.
• W2284398211 hasConcept C188987157 @default.
• W2284398211 hasConcept C19876734 @default.
• W2284398211 hasConcept C2776104367 @default.
• W2284398211 hasConcept C2779570518 @default.
• W2284398211 hasConcept C55493867 @default.
• W2284398211 hasConcept C61174792 @default.
• W2284398211 hasConcept C86803240 @default.
• W2284398211 hasConcept C95444343 @default.
• W2284398211 hasConceptScore W2284398211C104292427 @default.
• W2284398211 hasConceptScore W2284398211C104317684 @default.
• W2284398211 hasConceptScore W2284398211C12554922 @default.
• W2284398211 hasConceptScore W2284398211C160268369 @default.
• W2284398211 hasConceptScore W2284398211C170493617 @default.
• W2284398211 hasConceptScore W2284398211C185592680 @default.
• W2284398211 hasConceptScore W2284398211C188987157 @default.
• W2284398211 hasConceptScore W2284398211C19876734 @default.
• W2284398211 hasConceptScore W2284398211C2776104367 @default.
• W2284398211 hasConceptScore W2284398211C2779570518 @default.
• W2284398211 hasConceptScore W2284398211C55493867 @default.
• W2284398211 hasConceptScore W2284398211C61174792 @default.
• W2284398211 hasConceptScore W2284398211C86803240 @default.
• W2284398211 hasConceptScore W2284398211C95444343 @default.
• W2284398211 hasFunder F4320321108 @default.

• next